A Radiologist's Guide to the Changing Treatment Paradigm of Advanced Non–Small Cell Lung Cancer: The ASCO 2018 Molecular Testing Guidelines and Targeted Therapies
Lydia Y. Chen(University Hospitals of Cleveland), Nikhil H. Ramaiya(Brigham and Women's Hospital), Daniel A. Smith(University Hospitals of Cleveland), Amit Gupta(University of Washington), Bhanusupriya Somarouthu(Harvard University), Kianoush Ansari Gilani(University Hospitals of Cleveland)
Cited by 8
Related Papers
Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor
|New England Journal of Medicine|2010|871
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
|Nature Reviews Clinical Oncology|2021|810
Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
|Cancer Immunology Research|2019|313
Inhalation Toxicity and Lung Toxicokinetics of C60 Fullerene Nanoparticles and Microparticles
|Toxicological Sciences|2007|201
Induction of Inflammasome-dependent Pyroptosis by Carbon Black Nanoparticles
|Journal of Biological Chemistry|2011|188